Authors: Mathur, P Wharton, RQ Jonas, SK Saini, S Allen-Mersh, TG

Citation: P. Mathur et al., Relationship between tumour vascularity and circulating cancer cells in patients with colorectal carcinoma, EUR J SUR O, 27(4), 2001, pp. 354-358

Authors: Khan, ZAH Jonas, SK Feldmann, KA Patel, H Wharton, RQ Tarragona, A Ivison, A Allen-Mersh, TG

Citation: Zah. Khan et al., p53 mutation and response to hepatic arterial floxuridine in patients withcolorectal liver metastases, J CANC RES, 127(11), 2001, pp. 675-680

Authors: Khan, ZAJ Jonas, SK Le-Marer, N Patel, H Wharton, RQ Tarragona, A Ivison, A Allen-Mersh, TG

Citation: Zaj. Khan et al., p53 mutations in primary and metastatic tumors and circulating tumor cellsfrom colorectal carcinoma patients, CLIN CANC R, 6(9), 2000, pp. 3499-3504

Authors: Wharton, RQ Patel, H Jonas, SK Glover, C Weston, M Allen-Mersh, TG

Citation: Rq. Wharton et al., Venesection needle coring increases positive results with RT-PCR for detection of circulating cells expressing CEA mRNA, CLIN EXP M, 18(4), 2000, pp. 291-294

Authors: Davies, MM Jonas, SK Kaur, S Allen-Mersh, TG

Citation: Mm. Davies et al., Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume, BR J CANC, 82(5), 2000, pp. 1004-1008